Clinicopathological features of 171 cases of primary thyroid lymphoma: A long-term study involving 24553 patients with Hashimoto's disease

British Journal of Haematology

Volumn 153, Issue 2, 2011, Pages 236-243

  Watanabe, Natsuko ^a   Noh, Jaeduk Y ^a   Narimatsu, Hiroto ^b   Takeuchi, Kengo ^c   Yamaguchi, Takuhiro ^d   Kameyama, Kaori ^e   Kobayashi, Kazuhiko ^f   Kami, Masahiro ^g   Kubo, Atsushi ^a   Kunii, Yo ^a   Shimizu, Taeko ^a   Mukasa, Koji ^a   Otsuka, Fumiko ^a   Miyara, Ayako ^a   Minagawa, Akinobu ^a   Ito, Koichi ^a   Ito, Kunihiko ^a  

^a ITO HOSPITAL   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JR Tokyo General Hospital   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemotherapy; Clinical stage; Diffuse large B cell lymphoma; Irradiation; Mucosa associated lymphoid tissue

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; THYROID LYMPHOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HASHIMOTO DISEASE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 79953078052     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08606.x     Document Type: Article

References (21)

1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Dayan, C.M. & Daniels, G.H. (1996) Chronic autoimmune thyroiditis. New England Journal of Medicine, 335, 99-107.
3. Derringer, G.A., Thompson, L.D., Frommelt, R.A., Bijwaard, K.E., Heffess, C.S. & Abbondanzo, S.L. (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. American Journal of Surgical Pathology, 24, 623-639.
4. Fang, C., Xu, W. & Li, J.Y. (2010) A systematic review and meta-analysis of rituximab-based immunochemotherapy for subtypes of diffuse large B-cell lymphoma. Annals of Hematology, 89, 1107-1113.
5. Freeman, C., Berg, J.W. & Cutler, S.J. (1972) Occurrence and prognosis of extranodal lymphomas. Cancer, 29, 252-260.
6. Green, L.D., Mack, L. & Pasieka, J.L. (2006) Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. Journal of Surgical Oncology, 94, 725-736.
7. Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Muller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. & Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275-282.
8. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K. & Vardiman, J. (2000) Lymphoma classification - from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Annals of Oncology, 11, 3-10.
9. Holm, L.E., Blomgren, H. & Lowhagen, T. (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. New England Journal of Medicine, 312, 601-604.
10. Kato, I., Tajima, K., Suchi, T., Aozasa, K., Matsuzuka, F., Kuma, K. & Tominaga, S. (1985) Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Japanese Journal of Cancer Research, 76, 1085-1090.
11. Kon, Y.C. & DeGroot, L.J. (2003) Painful Hashimoto's thyroiditis as an indication for thyroidectomy: clinical characteristics and outcome in seven patients. Journal of Clinical Endocrinology and Metabolism, 88, 2667-2672.
12. Kossev, P. & Livolsi, V. (1999) Lymphoid lesions of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid, 9, 1273-1280.
13. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. & Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Journal of Clinical Oncology, 7, 1630-1636.
14. Molina, A. (2008) A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma. Annual Review of Medicine, 59, 237-250.
15. Niitsu, N., Okamoto, M., Nakamura, N., Nakamine, H., Bessho, M. & Hirano, M. (2007) Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Annals of Oncology, 18, 1203-1208.
16. Onal, C., Li, Y.X., Miller, R.C., Poortmans, P., Constantinou, N., Weber, D.C., Atasoy, B.M., Igdem, S., Ozsahin, M. & Ozyar, E. (2010) Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study. Annals of Oncology, 10, 1093.
17. Pedersen, R.K. & Pedersen, N.T. (1996) Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology, 28, 25-32.
18. Shigemasa, C., Ueta, Y., Mitani, Y., Taniguchi, S., Urabe, K., Tanaka, T., Yoshida, A. & Mashiba, H. (1990) Chronic thyroiditis with painful tender thyroid enlargement and transient thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 70, 385-390.
19. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. New England Journal of Medicine, 329, 987-994.
20. Thieblemont, C., Mayer, A., Dumontet, C., Barbier, Y., Callet-Bauchu, E., Felman, P., Berger, F., Ducottet, X., Martin, C., Salles, G., Orgiazzi, J. & Coiffier, B. (2002) Primary thyroid lymphoma is a heterogeneous disease. Journal of Clinical Endocrinology and Metabolism, 87, 105-111.
21. Zinzani, P.L., Magagnoli, M., Galieni, P., Martelli, M., Poletti, V., Zaja, F., Molica, S., Zaccaria, A., Cantonetti, A.M., Gentilini, P., Guardigni, L., Gherlinzoni, F., Ribersani, M., Bendandi, M., Albertini, P. & Tura, S. (1999) Non-gastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. Journal of Clinical Oncology, 17, 1254.